<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-5906191018964181307</id><updated>2012-01-03T01:20:03.172-08:00</updated><category term='IMGG'/><title type='text'>Stockshealthcare</title><subtitle type='html'>A blog to analyze stocks and companies in the healthcare, biomedical engineering, and biotechnology sectors that have pending regulatory issues(eg FDA approval) or other positive/negative price catalysts.
All serious contributors are welcome.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://stockshealthcare.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5906191018964181307/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://stockshealthcare.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>A S Galib</name><uri>http://www.blogger.com/profile/16807352174441393587</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='29' height='32' src='http://2.bp.blogspot.com/_UC0j4IdGovE/SzBci8OMZpI/AAAAAAAAACU/aEahmIcOp3U/S220/photo.glb2.JPG'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>2</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-5906191018964181307.post-5990741217272765461</id><published>2009-12-30T11:11:00.000-08:00</published><updated>2010-01-30T19:43:01.444-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='IMGG'/><title type='text'>IMGG post 2</title><content type='html'>&lt;span style="font-weight:bold;"&gt;READ POST 1 FIRST&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Seeking &lt;span style="font-weight:bold;"&gt;serious contributors&lt;/span&gt; for this blog. Email me with academic/professional background, to get author permission. If you have written a report please send it to me at asgalib20@gmail.com.&lt;br /&gt;&lt;br /&gt;Further analysis of the prospects of &lt;span style="font-weight:bold;"&gt;DViS&lt;/span&gt; in some &lt;span style="font-weight:bold;"&gt;clinical settings&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;Imaging parameters the DViS will address:&lt;br /&gt;&lt;br /&gt; A. Uses &lt;span style="font-weight:bold;"&gt;fluoroscopic technology&lt;/span&gt; with a rotating gantry, takes X-rays that is constructed into 3D images. So probably(since only one 3D image is available), the skeletal structures will be well defined, and the traumatologist and orthopedician may have speedy real time access to suspected fractures and dislocations. So the real value add in, is the image reconstruction technology.If DViS can produce &lt;span style="font-weight:bold;"&gt;enhanced tissue differentiation&lt;/span&gt;, that will be the plum in the pudding.&lt;br /&gt;B. Real time imaging.&lt;br /&gt;C. Ability to be transported to the patient's bed side. In case of CT or MRI, the patient has to be transferred.&lt;br /&gt;Advantages in emergency traumatology:&lt;br /&gt;1. Real time access- Current X-ray machines requires some time before the films can be processed and developed&lt;br /&gt;2. &lt;span style="font-weight:bold;"&gt;Less radiation&lt;/span&gt; than X-ray or CT scan. &lt;br /&gt;3. The healthcare professional may be able to take a &lt;span style="font-weight:bold;"&gt;quick decision&lt;/span&gt; regarding the best possible management protocol. &lt;br /&gt;4. The fractures and dislocations are often fixed or operated upon by using the C-Arm. The 3D images produced by DViS may in all probability &lt;span style="font-weight:bold;"&gt;enhance procedural parameters&lt;/span&gt; in the hands of the trained orthopedician. Parameters that can be addressed are:&lt;br /&gt;a. &lt;span style="font-weight:bold;"&gt;Safety and accessibility&lt;/span&gt;.&lt;br /&gt;b. &lt;span style="font-weight:bold;"&gt;Speedier procedures&lt;/span&gt;.&lt;br /&gt;c. An important point to note- Imaging itself is a means to an end, the &lt;span style="font-weight:bold;"&gt;complicated anatomy&lt;/span&gt; of the target region and the &lt;span style="font-weight:bold;"&gt;expertise and experience&lt;/span&gt;, of the doctor is also important(maybe more).&lt;br /&gt;d. So if doctors are willing to &lt;span style="font-weight:bold;"&gt;get trained&lt;/span&gt; in procedures, that are &lt;span style="font-weight:bold;"&gt;DViS assisted&lt;/span&gt;, the results should be better.&lt;br /&gt;&lt;br /&gt;So,it &lt;span style="font-weight:bold;"&gt;may be&lt;/span&gt; possible for DViS, at this point of time, to &lt;span style="font-weight:bold;"&gt;supercede existing modalities&lt;/span&gt; in the ER and traumatology settings. Let's hope for the best.&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;&lt;br /&gt;Legal disclaimer&lt;/span&gt;: The author may or may not have significant holdings in the company discussed.&lt;br /&gt;&lt;br /&gt;In my opinion the most important positive price catalyst are two:&lt;br /&gt;1. FDA approval, provided they have experienced doctors on their board.&lt;br /&gt;2. Positive feedback from physicians, interventional radiologists and other doctors and surgeons who base their clinical practice on imaging modalities.(Sadly I found only one person claiming to be a physician, and said prospects are good. We need feedback from a healthcare professional who has seen the system in action)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5906191018964181307-5990741217272765461?l=stockshealthcare.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://stockshealthcare.blogspot.com/feeds/5990741217272765461/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://stockshealthcare.blogspot.com/2009/12/imgg-continued.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5906191018964181307/posts/default/5990741217272765461'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5906191018964181307/posts/default/5990741217272765461'/><link rel='alternate' type='text/html' href='http://stockshealthcare.blogspot.com/2009/12/imgg-continued.html' title='IMGG post 2'/><author><name>A S Galib</name><uri>http://www.blogger.com/profile/16807352174441393587</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='29' height='32' src='http://2.bp.blogspot.com/_UC0j4IdGovE/SzBci8OMZpI/AAAAAAAAACU/aEahmIcOp3U/S220/photo.glb2.JPG'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5906191018964181307.post-8152488763279345877</id><published>2009-12-24T19:17:00.000-08:00</published><updated>2010-01-11T13:52:35.456-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='IMGG'/><title type='text'>Stock Analysis. IMGG</title><content type='html'>Company-&lt;strong&gt;Imaging3 Inc&lt;/strong&gt;.Ticker-&lt;strong&gt;IMGG&lt;/strong&gt;&lt;br /&gt;Product-&lt;strong&gt;Dominion Volumetric Imaging Scanner, the DViS&lt;/strong&gt;.&lt;br /&gt;According to the company website, DViS produces high quality, medical grade, real-time 3D images.&lt;br /&gt;As claimed the &lt;strong&gt;main advantages &lt;/strong&gt;are:&lt;br /&gt;1. Can produce CT “like” imagery.&lt;br /&gt;2. Uses dramatically less radiation.&lt;br /&gt;3. Mobility –can be shifted from room to room.&lt;br /&gt;4. Decreased imaging time.&lt;br /&gt;5. Broad application along multiple disciplines.&lt;br /&gt;6. Enhances procedural parameters.&lt;br /&gt;7. Enables previously unfeasible procedures.&lt;br /&gt;8. Set up is easy and costs less than a CT system.&lt;br /&gt;9. Real time imaging.&lt;br /&gt;&lt;br /&gt;All said and done, the real challenge for DViS will be to address critical imaging issues,  in varied clinical settings. For the last several decades, as imaging technology, has evolved , it has become  a cornerstone of medical diagnostics and therapeutic procedures. DViS can win big if it can enhance physician acceptability, albeit by demonstrating the superiority of its technology, over other imaging modalities currently in use . Not to forget , established imaging protocols, are already in place in several medical  disciplines , like traumatology, interventional cardiology and cardiac surgery , general  surgery and its various superspecialities, which have gained acceptance over the years as standard protocols in patient management.&lt;br /&gt;A critical overview of DViS functionality vis-à-vis, in use imaging technologies, will clear part of the picture.&lt;br /&gt;&lt;strong&gt;Strategic Hurdles for DViS&lt;/strong&gt;.&lt;br /&gt;1. Address imaging issues in varied clinical settings.&lt;br /&gt;2. Increase acceptability among physicians, surgeons, and radiologists.&lt;br /&gt;3. Generate sells over time.&lt;br /&gt;4. FDA approval( this comes first).&lt;br /&gt;&lt;br /&gt;The big question: &lt;strong&gt;Does  DViS got what it takes?&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt; Yes and No. Strategic marketing is the key.More imaging slides posted on the website will be helpful. Say, a trauma centre physician or surgeon will need images of the spleen, liver and other abdominal organs.  A medical expert will need time critical information, regarding the status of the internal organs, and the site, nature and extent of the injury, to decide what kind of intervention, is most suitable for the patient. &lt;br /&gt;&lt;br /&gt;What is required , so that the retail investor can make an informed decision?&lt;br /&gt;For starters:&lt;br /&gt;1. More slides taken from real patients in different clinical conditions, showing clear visualizations of internal organs, blood supply etc.&lt;br /&gt;2. Detailed explanations about how Imaging3 plans to make this product more acceptable to healthcare professionals.&lt;br /&gt;3. Case by case, clinical scenarios, in which DVis has outperformed other imaging modalities in addressing key imaging and clinical issues.&lt;br /&gt;&lt;br /&gt;Watch out for the next report- Detailed analysis of probable clinical scenarios in which DViS may play a part.&lt;br /&gt;&lt;br /&gt;Disclaimer: The author may or may not hold significant holdings in the company discussed.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5906191018964181307-8152488763279345877?l=stockshealthcare.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://stockshealthcare.blogspot.com/feeds/8152488763279345877/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://stockshealthcare.blogspot.com/2009/12/stock-analyis.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5906191018964181307/posts/default/8152488763279345877'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5906191018964181307/posts/default/8152488763279345877'/><link rel='alternate' type='text/html' href='http://stockshealthcare.blogspot.com/2009/12/stock-analyis.html' title='Stock Analysis. IMGG'/><author><name>A S Galib</name><uri>http://www.blogger.com/profile/16807352174441393587</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='29' height='32' src='http://2.bp.blogspot.com/_UC0j4IdGovE/SzBci8OMZpI/AAAAAAAAACU/aEahmIcOp3U/S220/photo.glb2.JPG'/></author><thr:total>0</thr:total></entry></feed>
